Cluster composition

Functions

CategoryNameIntersectionWithQueryPValueGenesInTermGenesInQueryGenesInTermInQueryID
DomainZnF_C2HC

FAM90A14 FAM90A1 FAM90A7 FAM90A18 FAM90A9 FAM90A8 FAM90A10

3.75e-07551577SM00343
DomainZnf_CCHC

FAM90A14 FAM90A1 FAM90A7 FAM90A18 FAM90A9 FAM90A8 FAM90A10

3.75e-07551577IPR001878
DomainCadherin_2

PCDHB14 PCDHB11 PCDHB9 PCDHB7 PCDHB3 PCDH12

1.76e-05651576PF08266
DomainCadherin_N

PCDHB14 PCDHB11 PCDHB9 PCDHB7 PCDHB3 PCDH12

1.76e-05651576IPR013164
DomainCadherin_C

PCDHB14 PCDHB11 PCDHB9 PCDHB7 PCDHB3

2.61e-05421575IPR032455
DomainCadherin_C_2

PCDHB14 PCDHB11 PCDHB9 PCDHB7 PCDHB3

2.61e-05421575PF16492
DomainCadherin_CS

FAT4 PCDHB14 PCDHB11 PCDHB9 PCDHB7 PCDHB3 PCDH12

3.77e-051091577IPR020894
DomainCADHERIN_1

FAT4 PCDHB14 PCDHB11 PCDHB9 PCDHB7 PCDHB3 PCDH12

4.75e-051131577PS00232
DomainCadherin

FAT4 PCDHB14 PCDHB11 PCDHB9 PCDHB7 PCDHB3 PCDH12

4.75e-051131577PF00028
DomainCADHERIN_2

FAT4 PCDHB14 PCDHB11 PCDHB9 PCDHB7 PCDHB3 PCDH12

5.03e-051141577PS50268
Domain-

FAT4 PCDHB14 PCDHB11 PCDHB9 PCDHB7 PCDHB3 PCDH12

5.03e-0511415772.60.40.60
DomainCA

FAT4 PCDHB14 PCDHB11 PCDHB9 PCDHB7 PCDHB3 PCDH12

5.32e-051151577SM00112
DomainCadherin-like

FAT4 PCDHB14 PCDHB11 PCDHB9 PCDHB7 PCDHB3 PCDH12

5.62e-051161577IPR015919
DomainCadherin

FAT4 PCDHB14 PCDHB11 PCDHB9 PCDHB7 PCDHB3 PCDH12

6.27e-051181577IPR002126
DomainLeu-rich_rpt

NLRP11 CNTRL LGR4 PIDD1 ELFN2 LRFN4 CD14 PKD1 LGR6 PRAME

1.01e-0427115710IPR001611
Domain-

NLRP11 CNTRL LGR4 PIDD1 ELFN2 LRFN4 CD14 PKD1 LGR6 PRAME

3.95e-04321157103.80.10.10
DomainL_dom-like

NLRP11 CNTRL LGR4 PIDD1 ELFN2 LRFN4 CD14 PKD1 LGR6 PRAME

4.67e-0432815710IPR032675
DomainLRR_1

CNTRL LGR4 PIDD1 ELFN2 LRFN4 CD14 LGR6 PRAME

5.39e-042191578PF00560
DomainARM-type_fold

CEP104 MYBBP1A NBEAL1 TOGARAM1 HUWE1 RALGAPA2 NOP9 PELP1 PI4KA ASPM

6.04e-0433915710IPR016024
DomainLRR_TYP

CNTRL LGR4 PIDD1 ELFN2 LRFN4 PKD1 LGR6

7.54e-041771577SM00369
DomainLeu-rich_rpt_typical-subtyp

CNTRL LGR4 PIDD1 ELFN2 LRFN4 PKD1 LGR6

7.54e-041771577IPR003591
Domain-

EPPK1 EVPL

1.03e-03615723.90.1290.10
DomainGphrmn_rcpt_fam

LGR4 LGR6

1.03e-0361572IPR002131
DomainCAMSAP_CH

ASPM VAV3

1.43e-0371572PF11971
DomainPlectin

EPPK1 EVPL

1.43e-0371572PF00681
DomainPlectin_repeat

EPPK1 EVPL

1.43e-0371572IPR001101
DomainCAMSAP_CH

ASPM VAV3

1.43e-0371572IPR022613
DomainPLEC

EPPK1 EVPL

1.43e-0371572SM00250
Pubmed

Characterization and evolution of the novel gene family FAM90A in primates originated by multiple duplication and rearrangement events.

FAM90A14 FAM90A2P FAM90A1 FAM90A17 FAM90A19 FAM90A22 FAM90A23 FAM90A7 FAM90A18 FAM90A9 FAM90A8 FAM90A16 FAM90A10

4.15e-24251751317684299
Pubmed

Analysis of the multi-copy gene family FAM90A as a copy number variant in different ethnic backgrounds.

FAM90A14 FAM90A2P FAM90A17 FAM90A19 FAM90A22 FAM90A23 FAM90A7 FAM90A9 FAM90A8 FAM90A16 FAM90A10

4.88e-20231751118602769
Pubmed

Placental PPARγ regulates spatiotemporally diverse genes and a unique metabolic network.

FAM90A14 FAM90A1 FAM90A17 FAM90A19 FAM90A22 FAM90A26 FAM90A23 PXYLP1 FAM90A7 FAM90A9 FAM90A8 FAM90A10

4.86e-111641751222967998
Pubmed

A central chaperone-like role for 14-3-3 proteins in human cells.

KIF13B KIF26B HJURP C19orf47 USP43 IRS1 CEP192 AKT1S1 PABIR2 FAM171A1 ZNF106 WWC2 VPS13D PHLDB1 PANK2 PI4KA PHACTR4 RASSF8 PARD3 SRRM2

1.58e-088611752036931259
Pubmed

The human and murine protocadherin-beta one-exon gene families show high evolutionary conservation, despite the difference in gene number.

PCDHB14 PCDHB11 PCDHB9 PCDHB7 PCDHB3

4.44e-0820175511322959
Pubmed

Protocadherins.

PCDHB14 PCDHB11 PCDHB9 PCDHB3

4.27e-0713175412231349
Pubmed

A striking organization of a large family of human neural cadherin-like cell adhesion genes.

PCDHB14 PCDHB11 PCDHB9 PCDHB7 PCDHB3 PCDH12

1.77e-0672175610380929
Pubmed

Cadherin superfamily genes: functions, genomic organization, and neurologic diversity.

PCDHB14 PCDHB11 PCDHB9 PCDHB7 PCDHB3 PCDH12

2.08e-0674175610817752
Pubmed

Phylogenetic analysis of the cadherin superfamily allows identification of six major subfamilies besides several solitary members.

PCDHB14 PCDHB11 PCDHB9 PCDHB7 PCDHB3 PCDH12

2.63e-0677175610835267
Pubmed

Large exons encoding multiple ectodomains are a characteristic feature of protocadherin genes.

PCDHB14 PCDHB11 PCDHB9 PCDHB7 PCDHB3 PCDH12

3.29e-0680175610716726
Pubmed

Clustered gamma-protocadherins regulate cortical interneuron programmed cell death.

PCDHB14 PCDHB11 PCDHB9 PCDHB7 PCDHB3

1.03e-0557175532633719
Pubmed

CTCF Governs the Identity and Migration of MGE-Derived Cortical Interneurons.

PCDHB14 PCDHB11 PCDHB9 PCDHB7 PCDHB3

1.12e-0558175530377227
Pubmed

Phosphoproteome analysis of the human mitotic spindle.

MYBBP1A EPPK1 TERT MISP PELP1 UBR5 ASPM SRRM2

1.21e-05210175816565220
Pubmed

Single-neuron diversity generated by Protocadherin-β cluster in mouse central and peripheral nervous systems.

PCDHB11 PCDHB7 PCDHB3

1.46e-0510175322969705
Pubmed

Comparative DNA sequence analysis of mouse and human protocadherin gene clusters.

PCDHB14 PCDHB11 PCDHB9 PCDHB7 PCDHB3

2.46e-0568175511230163
Pubmed

Immunosuppressive CD14+HLA-DR(low)/- monocytes in B-cell non-Hodgkin lymphoma.

HLA-DRB1 CD14

2.52e-052175221063024
Pubmed

HDAC6 is a therapeutic target in mutant GARS-induced Charcot-Marie-Tooth disease.

HDAC6 GARS1

2.52e-052175229415205
Pubmed

Knockdown of PRAS40 inhibits insulin action via proteasome-mediated degradation of IRS1 in primary human skeletal muscle cells.

IRS1 AKT1S1

2.52e-052175223460019
Pubmed

Lack of effect from genetic deletion of Hdac6 in a humanized mouse model of CMT2D.

HDAC6 GARS1

2.52e-052175238551018
Pubmed

Histone deacetylase 6 inhibition reduces cysts by decreasing cAMP and Ca2+ in knock-out mouse models of polycystic kidney disease.

HDAC6 PKD1

2.52e-052175228887310
Pubmed

Aberrant GlyRS-HDAC6 interaction linked to axonal transport deficits in Charcot-Marie-Tooth neuropathy.

HDAC6 GARS1

2.52e-052175229520015
Pubmed

Gly972Arg of IRS-1 and Lys121Gln of PC-1 polymorphisms act in opposite way in polycystic ovary syndrome.

IRS1 PKD1

2.52e-052175227785750
Pubmed

Genetic contribution of the CD14 -159C/T dimorphism in the promoter region in Japanese RA.

HLA-DRB1 CD14

2.52e-052175218565258
Pubmed

H19 inhibition increases HDAC6 and regulates IRS1 levels and insulin signaling in the skeletal muscle during diabetes.

HDAC6 IRS1

2.52e-052175235842608
Pubmed

The human desmin locus: gene organization and LCR-mediated transcriptional control.

SPEG DES

2.52e-052175216545539
Pubmed

USP7 targets XIAP for cancer progression: Establishment of a p53-independent therapeutic avenue for glioma.

NLRP11 MYBBP1A HTRA2 TERT PELP1 FAM186A ASPM SRRM2

2.64e-05234175836243803
Pubmed

Phosphoproteomic analysis of the developing mouse brain.

FAT4 MYBBP1A HUWE1 AKT1S1 NEK3 PELP1 CDCA7 SRRM2

3.76e-05246175815345747
Pubmed

TIF1beta/KAP-1 is a coactivator of the orphan nuclear receptor NGFI-B/Nur77.

MYBBP1A HDAC6 PELP1

5.45e-0515175319321449
Pubmed

Aurora B opposes PP1 function in mitosis by phosphorylating the conserved PP1-binding RVxF motif in PP1 regulatory proteins.

CEP192 UBR5 ASPM

6.68e-0516175329764992
Pubmed

PDZD7 is a modifier of retinal disease and a contributor to digenic Usher syndrome.

PDZD7 USH2A

7.53e-053175220440071
Pubmed

Association of TAP2 gene polymorphisms in Chinese patients with rheumatoid arthritis.

HLA-DRB1 TAP2

7.53e-053175214749980
Pubmed

Association of sequence variants on chromosomes 20, 11, and 5 (20q13.33, 11q23.3, and 5p15.33) with glioma susceptibility in a Chinese population.

TERT PHLDB1

7.53e-053175221350045
Pubmed

Exploring genetic variation that influences brain methylation in attention-deficit/hyperactivity disorder.

PIDD1 ARTN

7.53e-053175231582733
Pubmed

Synergistic contribution of CD14 and HLA loci in the susceptibility to Buerger disease.

HLA-DRB1 CD14

7.53e-053175217653770
Pubmed

Human telomerase is regulated by erythropoietin and transforming growth factor-beta in human erythroid progenitor cells.

EPO TERT

7.53e-053175217713555
Pubmed

Association of the TAP2*Bky2 allele with presence of SS-A/Ro and other autoantibodies in Japanese patients with systemic lupus erythematosus.

HLA-DRB1 TAP2

7.53e-053175212729048
Pubmed

Variation in the ATP-binding cassette transporter 2 gene is a separate risk factor for systemic lupus erythematosus within the MHC.

HLA-DRB1 TAP2

7.53e-053175219387463
Pubmed

HLA haplotype analysis in Finnish patients with rheumatoid arthritis.

HLA-DRB1 TAP2

7.53e-053175211229461
Pubmed

TAP1 and TAP2 gene polymorphism in rheumatoid arthritis in a population in eastern France.

HLA-DRB1 TAP2

7.53e-053175212047361
Pubmed

HDAC6 regulates epidermal growth factor receptor (EGFR) endocytic trafficking and degradation in renal epithelial cells.

HDAC6 PKD1

7.53e-053175223152903
Pubmed

Interactomes of Glycogen Synthase Kinase-3 Isoforms.

KIF26B TNRC6B CEP192 MISP VPS13D UBR5 RASSF8

9.64e-05209175736779422
Pubmed

E3 ubiquitin ligase RNF123 targets lamin B1 and lamin-binding proteins.

FAT4 KIF26B GARS1 PCDHB14 PIDD1 EVPL IRS1 ICE1 BCL3 HUWE1 MOGS PI4KA PKD1

9.81e-057361751329676528
Pubmed

Systematically defining selective autophagy receptor-specific cargo using autophagosome content profiling.

EPPK1 GPAA1 GARS1 LGR4 QTRT2 NIPSNAP3A ELAC2 TMEM33 ZNF106 MISP ARHGEF40 MOGS PELP1 UBR5 GLS CERCAM MRPL40 SRRM2

1.03e-0412971751833545068
Pubmed

Interactions between epiplakin and intermediate filaments.

EPPK1 DES

1.50e-044175216923132
Pubmed

Lgr4/Gpr48 negatively regulates TLR2/4-associated pattern recognition and innate immunity by targeting CD14 expression.

LGR4 CD14

1.50e-044175223589304
Pubmed

Usher Syndrome Type II

PDZD7 USH2A

1.50e-044175220301515
Pubmed

HLA-DRB1, TAP2/TAP1, and HLA-DPB1 haplotypes in Finnish juvenile idiopathic arthritis: more complexity within the MHC.

HLA-DRB1 TAP2

1.50e-044175215343265
Pubmed

Individual USH2 proteins make distinct contributions to the ankle link complex during development of the mouse cochlear stereociliary bundle.

PDZD7 USH2A

1.50e-044175226401052
Pubmed

Localization of PDZD7 to the stereocilia ankle-link associates this scaffolding protein with the Usher syndrome protein network.

PDZD7 USH2A

1.50e-044175223055499
Pubmed

Whirlin and PDZ domain-containing 7 (PDZD7) proteins are both required to form the quaternary protein complex associated with Usher syndrome type 2.

PDZD7 USH2A

1.50e-044175225406310
Pubmed

Comparison of TAP2 frequencies in type 1 diabetes patients and healthy controls from three ethnic groups indicates an African origin for the TAP2 G allele.

HLA-DRB1 TAP2

1.50e-044175212786999
Pubmed

CYLD negatively regulates cell-cycle progression by inactivating HDAC6 and increasing the levels of acetylated tubulin.

HDAC6 BCL3

1.50e-044175219893491
Pubmed

Prediction of the coding sequences of unidentified human genes. XII. The complete sequences of 100 new cDNA clones from brain which code for large proteins in vitro.

DMXL2 HDAC6 PPFIA4 UBR5 GLS

1.56e-04100175510048485
Pubmed

A dual-activity topoisomerase complex regulates mRNA translation and turnover.

EPPK1 SPEG C19orf47 AKNA IRS1 ICE1 CEP192 HUWE1 RALGAPA2 ELAC2 PHLDB1 HEG1 ARHGEF40 COQ4 PI4KA PKD1

1.58e-0411051751635748872
Pubmed

Comprehensive interactome profiling of the human Hsp70 network highlights functional differentiation of J domains.

DMXL2 TMEM201 MYBBP1A BCKDK MRPL27 SHMT1 CEP192 ELAC2 TMEM33 FAM171A1 MOGS UBR5 PI4KA GLS PHACTR4 ASPM MRPL40 PARD3 SRRM2

1.91e-0414871751933957083
Pubmed

Prediction of the coding sequences of mouse homologues of KIAA gene: IV. The complete nucleotide sequences of 500 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.

KIF13B DMXL2 PPFIA4 TOGARAM1 RALGAPA2 ELFN2 RFTN1 KRBA1 VPS13D GLS

2.13e-044931751015368895
Pubmed

Quantitative high-confidence human mitochondrial proteome and its dynamics in cellular context.

HTRA2 BCKDK GARS1 MRPL27 QTRT2 NIPSNAP3A HPDL ELAC2 VPS13D PANK2 PRELID3A FASTK COQ4 GLS MRPL40 TIMM29

2.15e-0411361751634800366
Pubmed

Global phosphoproteome of HT-29 human colon adenocarcinoma cells.

EPPK1 MISP UBR5 SRRM2

2.27e-0459175416083285
Pubmed

Polycystin-1 interacts with intermediate filaments.

DES PKD1

2.49e-045175211581269
Pubmed

Is TAP2*0102 allele involved in insulin-dependent diabetes mellitus (type 1) protection?

HLA-DRB1 TAP2

2.49e-045175215336779
Pubmed

A draft map of the human proteome.

EZHIP MGAM2

2.49e-045175224870542
Pubmed

Activity-Based Probes for HECT E3 Ubiquitin Ligases.

HUWE1 UBR5

2.49e-045175228425671
Pubmed

Dysfunction of the ciliary ARMC9/TOGARAM1 protein module causes Joubert syndrome.

CEP104 TOGARAM1

2.49e-045175232453716
Pubmed

HIV-1 Vpr protein inhibits telomerase activity via the EDD-DDB1-VPRBP E3 ligase complex.

TERT UBR5

2.49e-045175223612978
Pubmed

Deletion of PDZD7 disrupts the Usher syndrome type 2 protein complex in cochlear hair cells and causes hearing loss in mice.

PDZD7 USH2A

2.49e-045175224334608
Pubmed

Dyrk2-associated EDD-DDB1-VprBP E3 ligase inhibits telomerase by TERT degradation.

TERT UBR5

3.73e-046175223362280
Pubmed

Doublecortin induces mitotic microtubule catastrophe and inhibits glioma cell invasion.

KIF13B PPP1R9B

3.73e-046175219094064
Pubmed

Interaction between 5 genetic variants and allergy in glioma risk.

TERT PHLDB1

3.73e-046175220462933
Pubmed

Heart of glass anchors Rasip1 at endothelial cell-cell junctions to support vascular integrity.

RASIP1 HEG1

3.73e-046175226780829
Pubmed

Lgr5 homologues associate with Wnt receptors and mediate R-spondin signalling.

LGR4 LGR6

3.73e-046175221727895
Pubmed

Genetic risk profiles identify different molecular etiologies for glioma.

TERT PHLDB1

3.73e-046175220847058
Pubmed

Irisin Mediates Effects on Bone and Fat via αV Integrin Receptors.

MYBBP1A HDAC6 GPAA1 SPEG BCKDK GARS1 NIPSNAP3A IRS1 SIRPB2 HPDL TMEM33 HEG1 MOGS GLS CERCAM TAP2 PARP12 SLC66A3

4.03e-0414511751830550785
Pubmed

Polymorphisms in genes involved in neurodevelopment may be associated with altered brain morphology in schizophrenia: preliminary evidence.

PCDHB11 PCDH12 ASPM

4.60e-0430175319054571
Pubmed

HSF1 phosphorylation establishes an active chromatin state via the TRRAP-TIP60 complex and promotes tumorigenesis.

FAT4 EPPK1 CNTRL SEC22A MISP PHLDB1 LRFN4 UBR5 COQ4 PI4KA MEDAG TIMM29

4.66e-047541751235906200
Pubmed

Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function.

TMEM201 MYBBP1A HDAC6 GARS1 HUWE1 ELAC2 TMEM33 PHLDB1 ARHGEF40 UBR5 PI4KA GLS ASPM DDX20 PARD3 SRRM2 PARP12

5.08e-0413531751729467282
Pubmed

The roles of USH1 proteins and PDZ domain-containing USH proteins in USH2 complex integrity in cochlear hair cells.

PDZD7 USH2A

5.20e-047175228031293
Pubmed

Spatiotemporal expression patterns of R-spondins and their receptors, Lgrs, in the developing mouse telencephalon.

LGR4 LGR6

5.20e-047175237651925
Pubmed

Disruption of striated preferentially expressed gene locus leads to dilated cardiomyopathy in mice.

SPEG DES

5.20e-047175219118250
Pubmed

Lack of a strong association between HLA class II, tumour necrosis factor and transporter associated with antigen processing gene polymorphisms and virological response to alpha-interferon treatment in patients with chronic hepatitis C.

HLA-DRB1 TAP2

5.20e-047175215548263
Pubmed

Several regions in the major histocompatibility complex confer risk for anti-CCP-antibody positive rheumatoid arthritis, independent of the DRB1 locus.

HLA-DRB1 TAP2

5.20e-047175218309376
Pubmed

Interaction of the Wiskott-Aldrich syndrome protein with sorting nexin 9 is required for CD28 endocytosis and cosignaling in T cells.

PI4KA PIK3R5

5.20e-047175217242350
Pubmed

Polycystin-1 binds Par3/aPKC and controls convergent extension during renal tubular morphogenesis.

PKD1 PARD3

5.20e-047175224153433
Pubmed

Identification of novel cadherins expressed in human melanoma cells.

PCDHB14 PCDHB11

5.20e-04717529182820
Pubmed

Canonical WNT/β-Catenin Signaling Activated by WNT9b and RSPO2 Cooperation Regulates Facial Morphogenesis in Mice.

LGR4 LGR6

5.20e-047175232457899
Pubmed

Polymorphism of Immune Response Genes as a Factor for Predisposition to Development of Diseases.

HLA-DRB1 TAP2

5.20e-047175212687213
Pubmed

A Role for Sensory end Organ-Derived Signals in Regulating Muscle Spindle Proprioceptor Phenotype.

CYP2S1 HEG1 TNNI1

5.58e-0432175330926747
Pubmed

The functional interactome landscape of the human histone deacetylase family.

HDAC6 HJURP ZMYND8 HUWE1 UBR5 DDX20 SRRM2

6.86e-04289175723752268
Pubmed

R-spondins/Lgrs expression in tooth development.

LGR4 LGR6

6.91e-048175224616052
Pubmed

Confirmation of the novel association at the BTNL2 locus with ulcerative colitis.

HLA-DRB1 GPSM3

6.91e-048175219659809
Pubmed

Genome-wide association study identifies five susceptibility loci for glioma.

TERT PHLDB1

6.91e-048175219578367
Pubmed

Identification of Lgr5-independent spheroid-generating progenitors of the mouse fetal intestinal epithelium.

LGR4 LGR6

6.91e-048175224139799
Pubmed

Genetic variants in nuclear-encoded mitochondrial genes influence AIDS progression.

HTRA2 BCKDK GARS1 MRPL27 SHMT1 NIPSNAP3A ELAC2 PANK2 PRELID3A FASTK COQ4 GLS MRPL40

8.72e-049261751320877624
Pubmed

GSK3-mediated BCL-3 phosphorylation modulates its degradation and its oncogenicity.

HDAC6 BCL3

8.85e-049175215469820
Pubmed

Molecular characterization of the ventricular conduction system in the developing mouse heart: topographical correlation in normal and congenitally malformed hearts.

DES TNNI1

8.85e-049175211164852
Pubmed

Proteomic analysis reveals GIT1 as a novel mTOR complex component critical for mediating astrocyte survival.

AKT1S1 ARHGEF7

8.85e-049175227340174
Pubmed

The SCF-Fbxo40 complex induces IRS1 ubiquitination in skeletal muscle, limiting IGF1 signaling.

IRS1 UBR5

8.85e-049175222033112
Pubmed

Chromosome 7p11.2 (EGFR) variation influences glioma risk.

TERT PHLDB1

8.85e-049175221531791
Pubmed

An organelle-specific protein landscape identifies novel diseases and molecular mechanisms.

KIF13B MYBBP1A GPAA1 HTRA2 GARS1 QTRT2 AKT1S1 PABIR2 SOWAHA PANK2 DDX20 TIMM29 RASSF8 PARD3 PRAME RSPH10B

1.09e-0313211751627173435
Pubmed

Massively parallel DNA sequencing facilitates diagnosis of patients with Usher syndrome type 1.

PDZD7 USH2A

1.10e-0310175224618850
Pubmed

Characterization of SARS-CoV-2 proteins reveals Orf6 pathogenicity, subcellular localization, host interactions and attenuation by Selinexor.

MYBBP1A TNRC6B HUWE1 TMEM33 MOGS UBR5 PI4KA DDX20

1.14e-03408175833766124
InteractionYWHAH interactions

KIF13B EPPK1 KIF26B SPEG CNTRL HJURP C19orf47 USP43 IRS1 CEP192 HUWE1 AKT1S1 PABIR2 FAM171A1 ZNF106 WWC2 VPS13D PHLDB1 PANK2 CDCA7 ARHGEF7 PI4KA PHACTR4 GPSM3 PPP1R9B RASSF8 PARD3 SRRM2

2.80e-08110215728int:YWHAH
InteractionYWHAG interactions

KIF13B KIF26B SPEG HJURP C19orf47 USP43 LGR4 IRS1 CEP192 HUWE1 AKT1S1 PABIR2 FAM171A1 ZNF106 WWC2 VPS13D PHLDB1 LRFN4 PANK2 CDCA7 ARHGEF7 PI4KA PHACTR4 GPSM3 PPP1R9B RASSF8 PARD3 SRRM2

3.69e-07124815728int:YWHAG
InteractionYWHAQ interactions

KIF13B EPPK1 HDAC6 KIF26B SPEG HJURP C19orf47 USP43 IRS1 CEP192 TERT AKT1S1 PABIR2 FAM171A1 DES ZNF106 WWC2 VPS13D PHLDB1 PANK2 CDCA7 PHACTR4 GPSM3 RASSF8 PARD3

1.81e-06111815725int:YWHAQ
InteractionYWHAZ interactions

KIF13B DMXL2 HDAC6 KIF26B SPEG HJURP USP43 LGR4 IRS1 CEP192 HUWE1 TERT AKT1S1 PABIR2 FAM171A1 WWC2 VPS13D PHLDB1 PANK2 APH1A CDCA7 ARHGEF7 PHACTR4 GPSM3 PPP1R9B RASSF8 PARD3

3.53e-06131915727int:YWHAZ
InteractionYWHAB interactions

KIF13B KIF26B SPEG HJURP USP43 IRS1 CEP192 AKT1S1 PABIR2 FAM171A1 ZNF106 WWC2 VPS13D PHLDB1 LRFN4 PANK2 ARHGEF7 PHACTR4 GPSM3 PPP1R9B RASSF8 PARD3 SRRM2

3.90e-06101415723int:YWHAB
Cytoband8p23.1

FAM90A14 FAM90A2P FAM90A17 FAM90A19 FAM90A22 FAM90A23 FAM90A7 FAM90A18 FAM90A9 FAM90A8 FAM90A16 FAM90A10

9.62e-13154175128p23.1
CytobandEnsembl 112 genes in cytogenetic band chr8p23

FAM90A14 FAM90A2P FAM90A17 FAM90A19 FAM90A22 FAM90A23 FAM90A7 FAM90A18 FAM90A9 FAM90A8 FAM90A16 FAM90A10

1.31e-1023417512chr8p23
Cytoband5q31

PCDHB14 PCDHB11 PCDHB9 PCDHB7 PCDHB3 PCDH12

5.62e-0611517565q31
CytobandEnsembl 112 genes in cytogenetic band chr5q31

PCDHB14 PCDHB11 PCDHB9 PCDHB7 PCDHB3 PCDH12 SOWAHA CD14

2.09e-052981758chr5q31
GeneFamilyClustered protocadherins

PCDHB14 PCDHB11 PCDHB9 PCDHB7 PCDHB3

2.38e-056497520
GeneFamilyFibronectin type III domain containing|USH2 complex

PDZD7 USH2A

1.70e-0449721244
GeneFamilyArmadillo repeat containing|Protein phosphatase 1 regulatory subunits

HDAC6 CEP192 ELFN2 PHACTR4 PPP1R9B PARD3

4.31e-04181976694
GeneFamilyEF-hand domain containing|Plakins

EPPK1 EVPL

7.81e-048972939
CoexpressionGSE17186_CD21LOW_VS_CD21HIGH_TRANSITIONAL_BCELL_CORD_BLOOD_UP

HDAC6 PPFIA4 HLA-DRB1 ELAC2 SLC6A13 GLS VAV3 TAP2 PIK3R5

4.53e-062001629M7192
ToppCellControl-Endothelial-Endothelial-Alv_Gen_Intermediate|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

ROBO4 PCDH12 FAM171A1 RASIP1 PHACTR4 SCN9A PPP1R9B VAV3

5.22e-0718916485d7ae1ead7f4fbaeec26f651833c9c2106e1e4d1
ToppCellControl-Endothelial-Endothelial|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

FAT4 PCDH12 RALGAPA2 FAM171A1 RASIP1 PHACTR4 SCN9A VAV3

6.11e-071931648aff0649c73c634bc6ff0dc7759b4693a9236bf05
ToppCellControl-Endothelial|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

FAT4 PCDH12 RALGAPA2 FAM171A1 RASIP1 PHACTR4 SCN9A VAV3

6.11e-071931648c5f9fe03e64c211d4bcd4959e5b32f14841e336a
ToppCellLPS_anti-TNF-Endothelial|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type

ROBO4 PCDH12 TXNIP FAM171A1 RASIP1 HEG1 SCN9A PPP1R9B

8.00e-0720016481d105eeda5a2c51f9a4654ffc79b7e2348ad593b
ToppCellLPS_anti-TNF-Endothelial-Endothelial|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type

ROBO4 PCDH12 TXNIP FAM171A1 RASIP1 HEG1 SCN9A PPP1R9B

8.00e-07200164860d2cbf41f37f1b11eddb4c9d9246c9c1fc5a5af
ToppCellLPS_only-Endothelial-Endothelial-Alv_Cap|LPS_only / Treatment groups by lineage, cell group, cell type

ROBO4 PCDH12 TXNIP FAM171A1 RASIP1 HEG1 SCN9A PPP1R9B

8.00e-072001648432384faeade8e609154fab3d96c955a8ec868dd
ToppCellGlobus_pallidus-Endothelial-MURAL-M1(Rgs5Acta2)-M1_3-MURAL_Mural.Rgs5Acta2.Pappa2_(Mural.Rgs5Acta2.Pappa2)|Globus_pallidus / BrainAtlas - Mouse McCarroll V32

PCDHB11 PCDH12 GPR179 OLFML2A DES CARD6 CERCAM

9.43e-071411647a32947b13e888850c979a54c137512e4b96d2f36
ToppCellGlobus_pallidus-Endothelial-MURAL-M1(Rgs5Acta2)-M1_3-MURAL_Mural.Rgs5Acta2.Pappa2_(Mural.Rgs5Acta2.Pappa2)-|Globus_pallidus / BrainAtlas - Mouse McCarroll V32

PCDHB11 PCDH12 GPR179 OLFML2A DES CARD6 CERCAM

9.43e-0714116472cb651d63466fdcce011d1dd8de409ef439d03e7
ToppCellChildren_(3_yrs)-Mesenchymal-airway_smooth_muscle_cell-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor

FAT4 KIF26B SPEG LGR4 IRS1 DES LGR6

2.59e-061641647e3983f655cdba308fb192182829f17bef99ce0ba
ToppCell3'-GW_trimst-1-SmallIntestine-Endothelial-lymphatic_endothelial-LEC4_(STAB2+)|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract

EPO ROBO4 C20orf204 PCDH12 RALGAPA2 MEDAG VAV3

5.73e-061851647fb84fcf7f51f53489bcb3962fa9cb483e48257ed
ToppCell3'-GW_trimst-1-SmallIntestine-Endothelial-lymphatic_endothelial|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract

EPO ROBO4 C20orf204 PCDH12 RALGAPA2 MEDAG VAV3

5.93e-0618616479d250d5ae7cf9129be05b41d70cb6c3a046c5f1e
ToppCell(1)_Control_(PBS)-(1)_VE-Cad+_vascular_cells|(1)_Control_(PBS) / Stress and Cell class

ROBO4 RALGAPA2 TXNIP FAM171A1 RASIP1 ARHGEF7 VAV3

7.30e-061921647e16e49b302019474232ef4cc0ff217d33afe34cf
ToppCellRV-08._Macrophage|RV / Chamber and Cluster_Paper

DMXL2 SIRPB2 CD14 SCN9A ASPM VAV3 PIK3R5

7.55e-06193164712bf98a280f87e4d8f0c6887dfc855da72e47ac1
ToppCellLPS-IL1RA-Endothelial|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

ROBO4 FAT4 PCDH12 FAM171A1 RASIP1 HEG1 SCN9A

7.81e-06194164743f92b0533e26633dc94cce554045d641ef8fd76
ToppCellLPS-IL1RA-Endothelial-Endothelial|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

ROBO4 FAT4 PCDH12 FAM171A1 RASIP1 HEG1 SCN9A

7.81e-0619416471d39d968730a7e85b6161c1c8a6bd38afe9bcad7
ToppCellmLN-B_cell-B_cell_cycling|mLN / Region, Cell class and subclass

HJURP LGR4 HPDL CDCA7 LMLN ASPM MED12L

8.63e-061971647806dddcca85c82bd642008d930c8db16b613d88e
ToppCellsevere-unassigned|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class

RALGAPA2 RASIP1 CDCA7 AGMO SCN9A ASPM MED12L

8.63e-06197164770704b149b2820b8601d2495b7cd9cbe91eda262
ToppCellmLN-B_cell-B_cell_cycling|B_cell / Region, Cell class and subclass

HJURP LGR4 HPDL CDCA7 LMLN ASPM MED12L

8.63e-0619716472071526fe46de8359ea118ff78581eb4454aa55a
ToppCellmLN-(2)_B_cell-(24)_B_cell_cycling|mLN / shred on region, Cell_type, and subtype

HJURP LGR4 HPDL CDCA7 LMLN ASPM MED12L

8.63e-06197164770fff2d6723f259e18e7a21d22dc46d71f0759ce
ToppCellAdult-Immune-alveolar_macrophage_(MARCO_positive)-D231|Adult / Lineage, Cell type, age group and donor

DMXL2 HLA-DRB1 SIRPB2 TXNIP CD14 VAV3 PIK3R5

8.92e-06198164779a415e19cedde13a88f5043d71557363f102322
ToppCellLPS_IL1RA-Endothelial-Endothelial|LPS_IL1RA / Treatment groups by lineage, cell group, cell type

ROBO4 PCDH12 RALGAPA2 TXNIP FAM171A1 RASIP1 HEG1

9.53e-06200164772ea9882a8ed26fa1534aeb6ba0d1897dccc20c5
ToppCellLPS_IL1RA-Endothelial-Endothelial-Gen_Cap|LPS_IL1RA / Treatment groups by lineage, cell group, cell type

ROBO4 FAT4 PCDH12 RALGAPA2 FAM171A1 HEG1 UBR5

9.53e-062001647dccec522ab0d7fff62ad6273b02aa9022dbbb8eb
ToppCellSmart-start-Cell-Wel_seq-Non-neoplastic-Myeloid-Mono-Mono_hypoxia-F|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group

MARCHF2 CIRBP-AS1 CYP2S1 MAP10 RFTN1 CD14 PIK3R5

9.53e-06200164788d713dfc792e7609bf7ecfb28f87cb748088570
ToppCellLPS_IL1RA-Endothelial|LPS_IL1RA / Treatment groups by lineage, cell group, cell type

ROBO4 PCDH12 RALGAPA2 TXNIP FAM171A1 RASIP1 HEG1

9.53e-0620016475c092b2ecc081b5d04476c56333c338cd89ab984
ToppCellControl_saline-Endothelial-Endothelial-Gen_Cap|Control_saline / Treatment groups by lineage, cell group, cell type

ROBO4 FAT4 PCDH12 FAM171A1 OLFML2A RASIP1 HEG1

9.53e-0620016473b97920e1e6e2f09ddba2a861baa9c00c2970f4c
ToppCellControl_saline-Endothelial-Endothelial|Control_saline / Treatment groups by lineage, cell group, cell type

ROBO4 PCDH12 FAM171A1 RASIP1 HEG1 PPP1R9B VAV3

9.53e-062001647e77eba6172cabf85b8028638ed35299f2f079cd8
ToppCellLPS_IL1RA_TNF-Endothelial-Endothelial|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type

ROBO4 PCDH12 FAM171A1 RASIP1 HEG1 SCN9A PPP1R9B

9.53e-062001647a1fa6bae5a688faf488d6925cd3fad725dfa916b
ToppCellLPS_anti-TNF-Endothelial-Endothelial-Alv_Gen_Intermediate|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type

ROBO4 PCDH12 TXNIP FAM171A1 OLFML2A RASIP1 PPP1R9B

9.53e-06200164789a6da2bdedc6b1ad0675c8753bf2b763a99af6a
ToppCellLPS_IL1RA_TNF-Endothelial|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type

ROBO4 PCDH12 FAM171A1 RASIP1 HEG1 SCN9A PPP1R9B

9.53e-062001647d01cec331be3b03cef80e9536fc531285bcf00f6
ToppCellControl_saline-Endothelial|Control_saline / Treatment groups by lineage, cell group, cell type

ROBO4 PCDH12 FAM171A1 RASIP1 HEG1 PPP1R9B VAV3

9.53e-0620016473372c488a39fe812fa94e4f0564594186fea3db5
ToppCellsevere_COVID-19-cDC|severe_COVID-19 / disease group, cell group and cell class (v2)

ANKRD65 NIPSNAP3A CYP2S1 SCN9A ALPK3 RFPL2

2.57e-051571646ec1978e07e2214048d015d8bb793c1d9991f6e37
ToppCellfacs-Marrow-T-cells-24m-Lymphocytic-pre_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

PCDHB11 ELFN2 SLC22A12 LRFN4 GUCY2D SCN9A

2.66e-051581646f296ca24fdedc33f1d24b79e7660763114ce7fa3
ToppCellfacs-Marrow-T-cells-24m-Lymphocytic-precursor_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

PCDHB11 ELFN2 SLC22A12 LRFN4 GUCY2D SCN9A

2.66e-0515816468c7108f2c40d97a317762ba0b8eca76542b2ebaf
ToppCellkidney_cells-Adult_normal_reference-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_2|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group

LGR4 FAM171A1 LYPD1 GLS VAV3 TRPV5

3.06e-05162164636ddebe3bb172c992739353b7b049b2dde98b559
ToppCellCOPD-Myeloid-DC_Langerhans|Myeloid / Disease state, Lineage and Cell class

C20orf204 CYP2S1 RASIP1 DES RFTN1 SCN9A

3.28e-051641646a07c6e13c07a90bc37db0915eb14931eb8309a1e
ToppCellPND28-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

SPEG POPDC2 HPDL DES PRELID3A LGR6

3.88e-05169164688aa2246ede582c2e11de63228d76f520889ecb3
ToppCellPND28-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-ASMC|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

SPEG POPDC2 HPDL DES PRELID3A LGR6

3.88e-051691646a6a5b00912b653fad2ca7f096deaf35c9ef85e5b
ToppCellPND28-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-ASMC-ASMC_mature|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

SPEG POPDC2 HPDL DES PRELID3A LGR6

3.88e-05169164642a9b8c77d2a4d68b01e4db38f8a1af53c9c814f
ToppCellEndothelial-B-Donor_02|World / lung cells shred on cell class, cell subclass, sample id

ROBO4 C20orf204 PCDH12 FAM171A1 OLFML2A RASIP1

3.88e-0516916468889c9e8af1ab0b093d57b69abd80b59b3461be9
ToppCellPND10-Endothelial-Endothelial_blood-vessel-Macrovascular_EC-VEC-VEC_prolif|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

PCDHB9 PCDHB3 RALGAPA2 TSTD1 FAM171A1 HEG1

3.88e-051691646f086b50791e1c93e253eb5e8d6c4bf617b1416c3
ToppCellP15-Mesenchymal-mesenchymal_fibroblast-mesenchymal_progenitor_cell|P15 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase

LGR4 CEP192 NOP9 FAM151A AGMO LGR6

4.01e-051701646ba4ba66b624089ed50a9083176386c7941b4c7a3
ToppCelldroplet-Lung-18m-Hematologic-myeloid-classical_monocyte-classical_monocyte_l2-17-52|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype

PPFIA4 PCDHB3 CENPM LMLN MED12L RASSF8

4.28e-051721646ebeda7ef181cac0109be750a98e7589c615d2724
ToppCellPBMC-Severe-Myeloid-cDC-cDC-cDC_12|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)

ANKRD65 HLA-DRB1 NIPSNAP3A CYP2S1 CDCA7 SCN9A

4.42e-051731646a55f310c533432e9e26e400026a5b47245152976
ToppCellPBMC-Severe-Myeloid-cDC-cDC-cDC_12|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)

ANKRD65 HLA-DRB1 NIPSNAP3A CYP2S1 CDCA7 SCN9A

4.42e-0517316469c7386bf0a899882c733f0b4921a96afde032a7d
ToppCellmetastatic_Lymph_Node-Endothelial_cells-Lymphatic_ECs|metastatic_Lymph_Node / Location, Cell class and cell subclass

ROBO4 PCDHB11 PCDHB7 PCDH12 RASIP1 MEDAG

4.56e-051741646d551bc29afef071adf4c9bb80345352ec33441d8
ToppCellsaliva-Severe-critical_progression_d28-40-Lymphocytic-Lymphocytic_ILC-NK_cell-NK_c01-FCGR3A|Severe-critical_progression_d28-40 / Compartment, severity and other cell annotations on 10x 3' data (130k)

CNTRL ICE1 CEP192 CREBZF LRFN4 SLC66A3

4.56e-0517416469bb8159a62640756d18ecbade3bf32bcbb7dd590
ToppCellsaliva-Severe-critical_progression_d28-40-Lymphocytic-Lymphocytic_ILC|Severe-critical_progression_d28-40 / Compartment, severity and other cell annotations on 10x 3' data (130k)

CNTRL ICE1 CEP192 CREBZF LRFN4 SLC66A3

4.56e-051741646e70cc623a3a6aceec813ed852fec0c4240561133
ToppCellsaliva-Severe-critical_progression_d28-40-Lymphocytic-Lymphocytic_ILC-NK_cell|Severe-critical_progression_d28-40 / Compartment, severity and other cell annotations on 10x 3' data (130k)

CNTRL ICE1 CEP192 CREBZF LRFN4 SLC66A3

4.56e-051741646b6725086fe5a2b057c7c495ec63c970ac52c2580
ToppCellCOVID-mDC1-|COVID / Condition, Cell_class and T cell subcluster

ANKRD65 C19orf47 CYP2S1 SCN9A MED12L CERCAM

4.71e-05175164683a95d6fc2ddf3ec53f05825bbc982fb8d2ccd15
ToppCellCOVID-mDC1|COVID / Condition, Cell_class and T cell subcluster

ANKRD65 C19orf47 CYP2S1 SCN9A MED12L CERCAM

4.71e-051751646b9280444016e21c28131a61df65cc5c56d402412
ToppCellEndothelial-B-SSc-ILD_02|World / lung cells shred on cell class, cell subclass, sample id

ROBO4 PCDHB7 PCDH12 OLFML2A RASIP1 MEDAG

4.86e-051761646b288116a4588a1f9db9d49af92cea118937c9201
ToppCellIIH-CD8-CD4_Treg|IIH / Condition, Cell_class and T cell subcluster

TMEM201 C19orf47 C20orf204 PIDD1 FASTK DDX20

5.51e-051801646d1a8b25115c80e5a5bd0b8244167a98250ab9778
ToppCellMid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L5-6_PVALB_FAM150B|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types

CDCA7 SCN9A ASPM ALPK3 VAV3 RASSF8

5.68e-051811646af92b8b7f455210dab502ef6964f3a0162180759
ToppCelldroplet-Liver-hepatocytes-3m-Endothelial-endothelial_cell_of_hepatic_sinusoid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation

FAT4 PCDHB14 PCDHB11 FAM171A1 RASIP1 DES

5.68e-0518116464df7972f88117108698efd06b124b232f8588981
ToppCellEndothelial-B-IPF_02|World / lung cells shred on cell class, cell subclass, sample id

ROBO4 PCDHB14 POPDC2 PCDH12 FAM171A1 RASIP1

5.68e-0518116464fe0215d08f03d4e24749d70fce01b7aa22906fd
ToppCelldroplet-Liver-hepatocytes-3m-Endothelial|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation

FAT4 PCDHB14 PCDHB11 FAM171A1 RASIP1 DES

5.68e-051811646cbb530566893281289026bfd93adf721decd4ca3
ToppCellmild_COVID-19_(asymptomatic)-T/NK_proliferative|World / disease group, cell group and cell class (v2)

HJURP SHMT1 HPDL CDCA7 CENPM ASPM

5.86e-0518216469adf90bb2808f234d53b89ca0ae07380478204ad
ToppCellPrimary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L5_PVALB_CNTNAP3P2|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types

KIF26B CDCA7 SCN9A ASPM VAV3 RASSF8

6.04e-051831646121791ef84e7ce377ed6f5b7953af8865e04958e
ToppCellBac-SEP-Lymphocyte-T_NK-T_NK_proliferative|Bac-SEP / Disease, Lineage and Cell Type

HJURP USP43 SHMT1 CDCA7 CENPM ASPM

6.22e-051841646848d05afd5a2ef61fb8a09c0f5fa2a56fd5c160b
ToppCell3'-Adult-LargeIntestine-Hematopoietic-Myeloid-Lymphoid_DC|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract

KIF26B HLA-DRB1 C20orf204 RFTN1 GPSM3 PRAME

6.80e-051871646d69f4eee0304a7db226275ab77fc9d5d2b6f3a07
ToppCellPCW_07-8.5-Endothelial-Endothelial_mature-endo_capillary_(2)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung

ROBO4 HLA-DRB1 PCDH12 RASIP1 SLC22A10 CARD6

6.80e-051871646106f50ad85a92403037214f0e94702230284837f
ToppCellfacs-Brain_Non-Myeloid-Cortex-3m-Epithelial-neuronal_stem_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation

PCDHB14 SHMT1 PIDD1 TERT CDCA7 ASPM

6.80e-051871646a2076599b33ae6750961b573bfebcb9036fa4ee8
ToppCellfacs-Brain_Non-Myeloid-Cortex-3m-Epithelial-nan|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation

PCDHB14 SHMT1 PIDD1 TERT CDCA7 ASPM

6.80e-05187164638ee33295a21db4aae5ba085df033db9693e41c6
ToppCellfacs-Brain_Non-Myeloid-Cortex-3m-Epithelial|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation

PCDHB14 SHMT1 PIDD1 TERT CDCA7 ASPM

6.80e-051871646dbcec24d2c852964736c78e9d81650bff5c455ae
ToppCelltumor_Lymph_Node_/_Brain-Endothelial_cells-Tumor_ECs|tumor_Lymph_Node_/_Brain / Location, Cell class and cell subclass

ROBO4 PCDHB3 PCDH12 RASIP1 HEG1 AGMO

6.80e-051871646be5f8c5802b0fa8cc1e274fdf06b13eb8ceb8ad4
ToppCell10x_3'_v3-thymus_(10x_3'_v3)-lymphocytic-T_lymphocytic_-_developing-thymocyte|thymus_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type

ZMYND8 IRS1 TXNIP CDCA7 PXYLP1 PARD3

7.01e-051881646bcfc426b60d8e5a23a2360bfb68b32868fec9fbf
ToppCellFetal_29-31_weeks-Mesenchymal-airway_smooth_muscle_cell-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor

KIF26B SPEG LGR4 IRS1 DES LGR6

7.01e-051881646c29aaae3c5bb7cd6b9b3defd4d27afde3af19ba0
ToppCellFetal_29-31_weeks-Mesenchymal-airway_smooth_muscle_cell|Fetal_29-31_weeks / Lineage, Cell type, age group and donor

KIF26B SPEG IRS1 DES PHLDB1 LGR6

7.01e-0518816464d1e5f85342ae550086609d7680e32730b78b5d2
ToppCellCOPD-Stromal-SMC|Stromal / Disease state, Lineage and Cell class

SPEG ARTN DES ARHGEF7 ALPK3 LGR6

7.01e-0518816469ffef4b01d0ddd6913c9ed6be79aeaaabd5e41ed
ToppCellPBMC_fresh-frozen-Severe-critical_convalescent_d14-21-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c13-MKI67-CCL5_l|Severe-critical_convalescent_d14-21 / Compartment, severity and other cell annotations on 10x 3' data (130k)

HJURP LRFN4 CDCA7 CENPM ASPM ALG3

7.01e-05188164615146fd2c5592ea84d20b1fdd172b39cd60b5bed
ToppCellMesenchymal-airway_smooth_muscle_cell|World / Lineage, Cell type, age group and donor

KIF26B SPEG IRS1 DES PHLDB1 LGR6

7.43e-051901646645e56b02edc3702c7db917b8ecd5eed0decaf71
ToppCellLPS-IL1RA+antiTNF-Endothelial-Endothelial-Alv_Gen_Intermediate|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

ROBO4 PCDH12 FAM171A1 RASIP1 HEG1 SCN9A

7.43e-051901646a3c6eec6df052105ab78b7e3c78f94218d5912eb
ToppCellPBMC-Severe-Myeloid-Neutrophil-Neutrophil-Neu_4|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)

PIDD1 ARHGEF40 CENPM SCN9A ASPM CARD6

7.43e-0519016463f0c7d130f66faea778fe567604edf1b4cdf85b3
ToppCellLPS-IL1RA-Endothelial-Endothelial-Alv_Gen_Intermediate|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

FAT4 PCDH12 FAM171A1 RASIP1 SCN9A PPP1R9B

7.43e-051901646106ea0bb7b99c697ffc5443d72343df2484250c7
ToppCellRV-08._Macrophage|World / Chamber and Cluster_Paper

DMXL2 SIRPB2 SCN9A ASPM VAV3 PIK3R5

7.87e-051921646a1b5dc5beb97a23729b97b54fb4574d10d8fbfb3
ToppCellLPS-IL1RA+antiTNF-Endothelial|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

ROBO4 FAT4 PCDH12 FAM171A1 RASIP1 HEG1

7.87e-05192164604f5a2e3dd6beff027b89d66eefdd92036e041af
ToppCellLPS-IL1RA+antiTNF-Endothelial-Endothelial|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

ROBO4 FAT4 PCDH12 FAM171A1 RASIP1 HEG1

7.87e-051921646c07d7b40b2aa4eb27ac85801c014a656e2fd01dc
ToppCellPBMC-Severe-Myeloid-Neutrophil-Neutrophil-Neu_4|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)

PIDD1 ARHGEF40 CENPM SCN9A ASPM CARD6

7.87e-051921646c09dcc73ff9c3855a0f3d7bfa0d5c99c09a117f2
ToppCellkidney_cells-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Ascending_Vasa_Recta_Endothelial_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group

ROBO4 HLA-DRB1 PCDH12 OLFML2A RASIP1 HEG1

8.10e-051931646daefbfd3a3dd1351fbe94b9abfd807db44d56c24
ToppCellLPS-antiTNF-Endothelial-Endothelial|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

ROBO4 FAT4 PCDH12 FAM171A1 RASIP1 HEG1

8.10e-05193164602f633b016ab19bfa65bfd0cf32f000549a62148
ToppCellLPS-antiTNF-Endothelial|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

ROBO4 FAT4 PCDH12 FAM171A1 RASIP1 HEG1

8.10e-0519316465122b1ffba42de190061be34ecdc6176f84e56a3
ToppCellLPS-IL1RA-Endothelial-Endothelial-Activated_Alv_Cap|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

ROBO4 PCDH12 FAM171A1 RASIP1 HEG1 SCN9A

8.10e-051931646a3636c35ed25aabe2f1aba016c9fe125327bbfaf
ToppCellControl-NK_CD56bright|Control / Disease condition and Cell class

KIF26B PRSS33 BCL3 PLCH2 VAV3 RASSF8

8.10e-0519316468b1e7a226a6057e1097c1525984127b54e823876
ToppCellrenal_papilla_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Ascending_Vasa_Recta_Endothelial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group

ROBO4 HLA-DRB1 PCDH12 RASIP1 HEG1 MEDAG

8.10e-0519316461f978e102a029a6beb10913052cd0a20c7253e8e
ToppCellCOVID-19-Heart-Macrophage|Heart / Disease (COVID-19 only), tissue and cell type

DMXL2 SIRPB2 CD14 SCN9A VAV3 PIK3R5

8.33e-051941646f09675cd472200363c458952f00d2e41990800ee
ToppCell356C-Endothelial_cells-Endothelial-A_(Artery)|356C / Donor, Lineage, Cell class and subclass (all cells)

ROBO4 C20orf204 PCDH12 RALGAPA2 FAM171A1 RASIP1

8.33e-0519416462e5b195e02dcd5e9432b9a98b22e0478e65b9ba2
ToppCell356C-Endothelial_cells-Endothelial-A_(Artery)-|356C / Donor, Lineage, Cell class and subclass (all cells)

ROBO4 C20orf204 PCDH12 RALGAPA2 FAM171A1 RASIP1

8.33e-051941646b6b5b0ab506b05a005ba8a05a3c7f4c725ba9200
ToppCellLA-08._Macrophage|World / Chamber and Cluster_Paper

DMXL2 SIRPB2 CD14 SCN9A VAV3 PIK3R5

8.33e-051941646c1805572bcc11b1cd29083329d7b5911489fb758
ToppCellLPS_only-Endothelial|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

ROBO4 FAT4 PCDH12 FAM171A1 RASIP1 HEG1

8.33e-05194164658f069efdefa0366033764446b9d6ffd4a17807e
ToppCellLPS_only-Endothelial-Endothelial|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

ROBO4 FAT4 PCDH12 FAM171A1 RASIP1 HEG1

8.33e-051941646bfd92ec75facb0ba55c31e5f2e089d983b3d0169
ToppCellLA-09._Endothelium_I|World / Chamber and Cluster_Paper

ROBO4 HLA-DRB1 RALGAPA2 RASIP1 RFTN1 HEG1

8.57e-051951646fc95457a298b5d0dab687d9ee7e225a7f7b9a0d4
ToppCellfacs-Lung-nan-3m-Endothelial|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation

ROBO4 HJURP TXNIP OLFML2A RASIP1 HEG1

8.57e-0519516467f9b7f15006610ad591063d90e90367bd6083c7f
ToppCellEndothelial|World / shred by cell class for bronchial biopsy

ROBO4 HLA-DRB1 C20orf204 PCDH12 RASIP1 HEG1

8.57e-051951646f0e46e859f7a9bdead3203889f7e20fa21f76ff0
ToppCellkidney_cells-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Glomerular_Capillary_Endothelial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group

ROBO4 HLA-DRB1 PCDH12 OLFML2A RASIP1 HEG1

8.82e-05196164665d882c6e7f6d5778b8a5fd4fdaf012e1b9f6100
ToppCellrenal_papilla_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group

ROBO4 FAT4 HLA-DRB1 RASIP1 HEG1 MEDAG

8.82e-051961646e224338490691d92c1f70b57112fabdcc92b06a9
ToppCellPBMC-Control-cDC_3|Control / Compartment, Disease Groups and Clusters

HLA-DRB1 AKNA HPDL TXNIP PI4KA PPP1R9B

8.82e-05196164609d197b321ff9f13c0672ea059c850845b0dbbd5
ToppCelltumor_Lung-Endothelial_cells|tumor_Lung / Location, Cell class and cell subclass

ROBO4 PCDH12 FAM171A1 OLFML2A RASIP1 HEG1

9.06e-0519716466870b311c54a73723768276a58456620f5217d43
ToppCellPCW_10-12-Endothelial-Endothelial_cycling-endo_proliferating2_(14)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung

ROBO4 HJURP PCDH12 RASIP1 SLC22A10 ASPM

9.06e-051971646491e12a5fca06b86443c0173f5fa750ea3b8a715
ToppCell3'-Child09-12-SmallIntestine-Endothelial-blood_vessel_EC-arterial_capillary|Child09-12 / Celltypes from developing, pediatric, Crohn's, & adult GI tract

ROBO4 ANKRD65 PCDH12 OLFML2A RASIP1 HEG1

9.06e-051971646947042f888335c0829d4d5daeb623973eadb3348
ToppCellFetal_29-31_weeks-Immune-alveolar_macrophage_(MARCO_positive)-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor

DMXL2 HLA-DRB1 SIRPB2 CD14 VAV3 PIK3R5

9.32e-051981646ab70bf89690410221ec7aa3149bb50ac34433f99
DiseaseUsher syndrome type 2A (is_implicated_in)

PDZD7 USH2A

2.47e-0521472DOID:0110838 (is_implicated_in)
DiseaseUSHER SYNDROME, TYPE IIA

PDZD7 USH2A

2.47e-0521472276901
DiseaseUSHER SYNDROME, TYPE IIA

PDZD7 USH2A

2.47e-0521472C1848634
DiseaseUsher syndrome type 2A

PDZD7 USH2A

2.47e-0521472cv:C1848634
DiseaseUsher syndrome type 2

PDZD7 USH2A

7.37e-0531472C0339534
Diseasegallbladder carcinoma (is_implicated_in)

TERT UBR5

2.44e-0451472DOID:4948 (is_implicated_in)
DiseaseUsher Syndrome, Type II

PDZD7 USH2A

2.44e-0451472C1568249
Diseaseglaucoma (biomarker_via_orthology)

EPO TXNIP RFTN1

3.62e-04281473DOID:1686 (biomarker_via_orthology)
Diseasepolycystic liver disease (implicated_via_orthology)

HDAC6 PKD1

5.09e-0471472DOID:0050770 (implicated_via_orthology)
Diseasehelping behavior measurement

TMEM33 USH2A

6.77e-0481472EFO_0008538
Diseaseidiopathic pulmonary fibrosis (is_implicated_in)

HLA-DRB1 TERT

8.67e-0491472DOID:0050156 (is_implicated_in)
Diseaseisovalerate measurement

FAM171A1 USH2A

8.67e-0491472EFO_0021051
DiseaseCongenital disorder of glycosylation

MAN2C1 MOGS ALG3

8.99e-04381473cv:C0282577
Diseaseresting heart rate

EPPK1 SPEG C19orf47 DES ARHGEF40

9.22e-041491475EFO_0004351
DiseaseAlzheimer disease, peptic ulcer disease

HLA-DRB1 BCL3 RASIP1

9.71e-04391473MONDO_0004247, MONDO_0004975
Diseaseceliac disease (is_implicated_in)

HLA-DRB1 CD14

1.08e-03101472DOID:10608 (is_implicated_in)
DiseaseUterine leiomyoma, estrogen-receptor negative breast cancer

TNRC6B TERT

1.08e-03101472EFO_1000650, HP_0000131
Diseaseglaucoma (is_implicated_in)

EPO HLA-DRB1

1.08e-03101472DOID:1686 (is_implicated_in)
Diseasepulmonary tuberculosis (is_implicated_in)

HLA-DRB1 CD14 TAP2

1.21e-03421473DOID:2957 (is_implicated_in)
Diseaseaspirin-induced respiratory disease (is_implicated_in)

HLA-DRB1 TAP2

1.32e-03111472DOID:0080822 (is_implicated_in)
Diseasesmall vessel stroke

FAT4 NBEAL1 RALGAPA2 ZNF106

1.38e-03961474EFO_1001504
Diseaseanti-Epstein Barr virus antibody measurement

HLA-DRB1 MED12L

1.57e-03121472EFO_0009273
Diseaserheumatoid arthritis, smoking status measurement, ACPA-positive rheumatoid arthritis

HLA-DRB1 TAP2

1.85e-03131472EFO_0000685, EFO_0006527, EFO_0009459
Diseasediabetic angiopathy (is_implicated_in)

EPO HLA-DRB1

1.85e-03131472DOID:11713 (is_implicated_in)
DiseaseDEAFNESS, AUTOSOMAL RECESSIVE (disorder)

DMXL2 PDZD7

1.85e-03131472C1846647
Diseasechromosome 22q11.2 deletion syndrome, distal (implicated_via_orthology)

PI4KA MRPL40

2.16e-03141472DOID:0060413 (implicated_via_orthology)
Diseasepolycystic kidney disease (implicated_via_orthology)

HDAC6 PKD1

2.16e-03141472DOID:0080322 (implicated_via_orthology)
Diseaseallergic disease (is_implicated_in)

HLA-DRB1 CD14

2.48e-03151472DOID:1205 (is_implicated_in)
Diseasesarcoidosis (is_implicated_in)

HLA-DRB1 CD14

2.83e-03161472DOID:11335 (is_implicated_in)
DiseaseIGA glomerulonephritis

HLA-DRB1 VAV3 TAP2

3.06e-03581473EFO_0004194
DiseaseUterine leiomyoma, estrogen-receptor positive breast cancer

TNRC6B TERT

3.58e-03181472EFO_1000649, HP_0000131
Diseasecortical thickness

NBEAL1 PCDHB11 LGR4 TNRC6B ELAC2 ZNF106 VPS13D PHLDB1 ARHGEF40 PI4KA GLS PKD1 PARD3

3.85e-03111314713EFO_0004840
DiseaseCongenital hernia of foramen of Morgagni

EPO DES

3.99e-03191472C0265699
DiseaseCongenital hernia of foramen of Bochdalek

EPO DES

3.99e-03191472C0265700
Diseaseankylosing spondylitis (is_implicated_in)

HLA-DRB1 TAP2

3.99e-03191472DOID:7147 (is_implicated_in)
DiseaseLiver carcinoma

EPO HJURP IRS1 TERT OLFML2A CENPM SLC22A10 ASPM

4.01e-035071478C2239176
DiseaseCoronary Arteriosclerosis

EPO IRS1 TERT

4.22e-03651473C0010054
DiseaseCoronary Artery Disease

EPO IRS1 TERT

4.22e-03651473C1956346
DiseaseAlzheimer's disease (is_implicated_in)

EPO HLA-DRB1 IRS1 TAP2

4.36e-031321474DOID:10652 (is_implicated_in)
Diseaseglaucoma (is_marker_for)

EPO RFTN1

4.42e-03201472DOID:1686 (is_marker_for)
Diseasemyelodysplastic syndrome (is_marker_for)

TERT PRAME

4.42e-03201472DOID:0050908 (is_marker_for)
DiseaseMicrocephaly

DONSON PCDH12 AGMO

4.60e-03671473C0025958
DiseaseCongenital diaphragmatic hernia

EPO DES

4.86e-03211472C0235833
DiseaseLymphoma, Diffuse

HLA-DRB1 SHMT1

4.86e-03211472C3714542
DiseaseLow Grade Lymphoma (neoplasm)

HLA-DRB1 SHMT1

4.86e-03211472C0079747
DiseaseLymphoma, Intermediate-Grade

HLA-DRB1 SHMT1

4.86e-03211472C0079741
DiseaseHigh Grade Lymphoma (neoplasm)

HLA-DRB1 SHMT1

4.86e-03211472C0079740
DiseaseDiffuse Mixed-Cell Lymphoma

HLA-DRB1 SHMT1

4.86e-03211472C0079757
DiseaseLymphoma, Undifferentiated

HLA-DRB1 SHMT1

4.86e-03211472C0024306
DiseaseReticulosarcoma

HLA-DRB1 SHMT1

4.86e-03211472C0024302
DiseaseLymphoma, Mixed-Cell

HLA-DRB1 SHMT1

4.86e-03211472C0024304

Protein segments in the cluster

PeptideGeneStartEntry
RARTGTELVLLTAAP

AKT1S1

21

Q96B36
RSRSLSPLIGSETLP

CNTRL

31

Q7Z7A1
STPTLASRGILGLSR

ARHGEF40

1491

Q8TER5
ATTAAAPTLRRLALS

C19orf47

321

Q8N9M1
APTLRRLALSSRSGL

C19orf47

326

Q8N9M1
DALTSISAGVLSRLP

AGMO

71

Q6ZNB7
TTLRIGRATDTLPAS

ACTR8

56

Q9H981
RTGESILSLLRDPSK

ALG3

311

Q92685
SILLSISSLGRTLRG

C20orf204

96

A0A1B0GTL2
SFRLDPVSGRLSTIS

FAT4

631

Q6V0I7
PVSGRLSTISSLDRE

FAT4

636

Q6V0I7
TLLLSPCTSRRLTGL

ALPK3

1231

Q96L96
PSLDSLGRRSSLSRL

ARHGEF7

751

Q14155
LGRRSSLSRLEPSDL

ARHGEF7

756

Q14155
IRRNLASPEGTLATL

DMXL2

1851

Q8TDJ6
LSSPRTRTGDVLLAE

DDX20

46

Q9UHI6
LGPALALRARSTSAT

BCKDK

21

O14874
LRTRLGSLALGAVPT

CIRBP-AS1

46

Q8TBR5
RGSVLASLSPLRKAS

FAM90A10

176

A6NDY2
LLGASRTLSLALDNP

ASPM

56

Q8IZT6
GLQGLETRRLSLPSS

HJURP

476

Q8NCD3
LDVLFSLLRTSPTRG

NBEAL1

1111

Q6ZS30
SDVQLILRRTGPSLS

RASSF8

71

Q8NHQ8
SSRLRLTGPVTDDAL

RASIP1

916

Q5U651
SALTRALASRTLAPQ

NIPSNAP3A

6

Q9UFN0
LPGSSAVRLASLRDL

RFTN1

51

Q14699
RGSVLASLSPLRKAS

FAM90A7

176

A6NKC0
RDLLLRSPAGVSATL

GLS

11

O94925
TALKSTGLRTSDPRL

GLS

161

O94925
SSLLDPSTGLALDRL

PCDH12

1036

Q9NPG4
SSGVAPRLSRSAELI

RSPH10B

356

P0C881
SSGVAPRLSRSAELI

RSPH10B2

356

B2RC85
RGSVLASLSPLRKAS

FAM90A23

176

A8MXZ1
LRVLLSAQTSPARLS

FASTK

36

Q14296
QPGLRRALSSDSILS

MISP

386

Q8IVT2
GSPLLLFLRDQTSSR

NOP9

316

Q86U38
SSLSLGLLPERSATL

FAM171A1

111

Q5VUB5
LPSLGTSRLTRADLG

KRBA1

236

A5PL33
RHTALGPRSASLLSL

GPSM3

46

Q9Y4H4
GPRSASLLSLQTELL

GPSM3

51

Q9Y4H4
LTDLGSRLLSQLERP

MAP10

181

Q9P2G4
LISRGDLSVTASTRP

MED12L

621

Q86YW9
RLLSTVIRALDTPSD

MARCHF2

46

Q9P0N8
GILRAPRAASTESLV

GPAA1

131

O43292
TSNRRVLLDTSIGPL

MGAM2

186

Q2M2H8
LPGSSRRRLLSSSLQ

GPR179

746

Q6PRD1
LSTALRARGLPVASV

GUCY2D

201

Q02846
SLVPERSFEGLSSLR

LGR6

151

Q9HBX8
GSLRKLTLSSNPLRS

NLRP11

746

P59045
RGSVLASLSPLRKAS

FAM90A1

176

Q86YD7
LRKRGSIPTSLTALS

PPFIA4

621

O75335
LASLSEDGRSPISIR

APH1A

101

Q96BI3
RARSPHDLSLASLLG

ARTN

156

Q5T4W7
RSSGLASKLPLRAVS

KIF26B

1791

Q2KJY2
ASKLPLRAVSGRISE

KIF26B

1796

Q2KJY2
LGLRSISTPSPESLR

EZHIP

456

Q86X51
LLLLGGLRASATSTP

LMLN

41

Q96KR4
LLLLTLALSGTRARG

CYP2S1

16

Q96SQ9
RGSVLASLSPLRKTS

FAM90A22

176

A8MWA6
RGSVLASLSPLRKAS

FAM90A14

176

P0C7W9
LRERLGALKVSPSAS

PDZD7

691

Q9H5P4
PGLLQESSRLRSLLE

EVPL

1146

Q92817
LSLARSLAVQRPASL

PI4KA

36

P42356
PSEAIRGLSALQSLR

LGR4

121

Q9BXB1
VGLLLSRGASPTLRT

ANKRD65

351

E5RJM6
TDGGPRTLRSLTVSL

HEG1

336

Q9ULI3
RGSVLASLSPLRKAS

FAM90A17

176

P0DV74
RLGALRLGSTSPRTL

PRSS33

91

Q8NF86
TNSRLARPTRLSLGD

IRS1

851

P35568
AVSSGPRLRLLLLES

PELP1

26

Q8IZL8
GITILVRRSSSPAEL

RALGAPA2

811

Q2PPJ7
RGSVLASLSPLRKAS

FAM90A16

176

P0DV73
PLLSASSRLGRALAE

HUWE1

1051

Q7Z6Z7
SSTLGRTRSLPITIE

PHACTR4

456

Q8IZ21
STSVGLRNADTLPRL

DPRX

96

A6NFQ7
RGSVLASLSPLRKAS

FAM90A19

176

P0DV76
RPSLTSISSGELRSL

MEDAG

11

Q5VYS4
PSATTLLSRGIVARL

NEK3

246

P51956
RLSLVIRSPSLLQSG

MYBBP1A

1301

Q9BQG0
VSSPAGILSLTLLER

HPDL

121

Q96IR7
SSRLGPLLDILADSR

MOGS

706

Q13724
LTRPSEFILLGLSSR

OR1L1

56

Q8NH94
RRSSSAPLIHGLSDL

PABIR2

21

Q7Z309
TPSILLALGSLFSSR

PARP12

686

Q9H0J9
RGSPALSSEALVRVL

PCDHB11

536

Q9Y5F2
LLFLRGTRIPSSTTL

PANK2

26

Q9BZ23
RGSVLASLSPLRKAS

FAM90A8

176

A6NJQ4
RGSPALSSEALVRVL

PCDHB14

536

Q9Y5E9
RGSPALSSEALVRVL

PCDHB7

536

Q9Y5E2
PTTLEARLRLLSSVT

QTRT2

226

Q9H974
RPDTRLQLTTGSSLF

SERPINA2

131

P20848
PVLLTRTGDSSARLR

CEP104

531

O60308
PLEATGLALSSLRLR

CD14

136

P08571
ESAGAISSPALTLRR

IFNW1

131

P05000
RALLTSGTSDPRARV

HTRA2

36

O43464
TLRSAKRLRLDTGSP

ICE1

1841

Q9Y2F5
SQLSGLPRRLRSTSL

LACTBL1

136

A8MY62
PDSILDTLTSRRLIS

CARD6

26

Q9BX69
SSGSAIPLLLRELNR

DNASE1L1

61

P49184
SVFPLGSEARSLSLR

LINC00322

216

Q6ZN03
LRPSLALLARLSSLG

FAM151A

421

Q8WW52
LGSLRASRLGTTRTP

DES

66

P17661
SALNLLSLLRSSEGP

CENPM

161

Q9NSP4
ERPRISTSTLDLGKL

COQ4

101

Q9Y3A0
VLSSPLALSGDTRPR

HLA-DRB1

21

P01911
VSGLRSLTTLLRALG

EPO

126

P01588
SVPREVLRLSLSSES

AKNA

1161

Q7Z591
LLRVGSVVLSSAPAL

C19orf73

101

Q9NVV2
SVRGSILSLSLLRAP

MAN2C1

876

Q9NTJ4
SSASALRPGLRTTIL

LYPD1

116

Q8N2G4
LGLPVAVSTLARDRS

CEP192

36

Q8TEP8
DLITALISPTTRGLR

DONSON

301

Q9NYP3
RGSVLASLSPLRKAS

FAM90A20P

176

A6NIJ5
RLSPSLRLSLASSAP

FAM186A

1731

A6NE01
PSTLIGSLRTLELGS

HDAC6

1046

Q9UBN7
SGSQKTLRSPRLDLT

CERCAM

566

Q5T4B2
LLPLVRTLVRSGADS

BCL3

321

P20749
RGSVLASLSPLRKAS

FAM90A5P

176

A8MXJ8
LDLSGSRETPSSILL

ZMYND8

1121

Q9ULU4
SASVIRVRDGLPLSA

SEC22A

6

Q96IW7
SHLGRRPTLAASLLL

SLC22A12

401

Q96S37
RGSVLASLSPLRKAS

FAM90A24P

176

P0C7X0
SLPASLAGLRSLRLL

PIDD1

231

Q9HB75
RSGTFPLALVLSSRV

PKD1

1351

P98161
RRLSAGLSLPLLTSV

PKD1

3891

P98161
LVLLLSGRPTRADSK

OLFML2A

16

Q68BL7
RGSPALSSEALVRVL

PCDHB3

536

Q9Y5E6
RRSSDPALIGLSTSV

PARD3

141

Q8TEW0
IISTILRIPSASGRS

OR6F1

221

Q8NGZ6
RGSPALSSEALVRVL

PCDHB9

536

Q9Y5E1
LRLGTPALTSRGLLE

SHMT1

401

P34896
LRLGAPEARRSATLS

KIF13B

1781

Q9NQT8
ASISLTESRGLFPRL

USH2A

26

O75445
LRSISLALRPTSGLL

MRPL40

6

Q9NQ50
IALALTAISLGTARP

SRRM2

2181

Q9UQ35
SGTLLLLAPATRNRE

TIMM29

91

Q9BSF4
TSPRRLVELAGQSLL

PRAME

21

P78395
PTVLRARASGIDLTA

SLC22A10

461

Q63ZE4
RGSVLASLSPLRKAS

FAM90A12P

176

A8MX19
RGSVLASLSPLRKAS

FAM90A9

176

A6NNJ1
RGSVLASLSPLRKAS

FAM90A13P

176

P0C7W8
RGSALASLSPLRKAS

FAM90A26

176

D6RGX4
GTLDLPALTRRLTAI

EPPK1

3096

P58107
SGTLDLPALTRRLTA

EPPK1

3626

P58107
GTLDLPALTRRLTAI

EPPK1

4161

P58107
SGTLDLPALTRRLTA

EPPK1

4696

P58107
ARPSLLLRRSLSAAS

GARS1

26

P41250
LPSLVRAILGTSRTL

PRELID3A

61

Q96N28
SDLGPIKSLRTLRAL

SCN9A

1281

Q15858
SLSVQGLSRASPVRL

SLC39A3

156

Q9BRY0
LATPLTVSLRALVAG

TAP2

71

Q03519
PVLAALRDLSRRGST

MRGPRG-AS1

61

Q2M3A8
TLSPVLSALGLSEAR

PXYLP1

381

Q8TE99
RGSVLASLSPLRKAS

FAM90A15P

176

P0C7V4
SSPLLRGSHSLELRA

ROBO4

656

Q8WZ75
TRSRSRILGSLDALP

CDCA7

181

Q9BWT1
ALLLALATSRRSPGQ

SIRPB2

306

Q5JXA9
SELDRPLQGTLTLLR

USP43

986

Q70EL4
PATLSLSLSLTLSGR

AVPR1B

386

P47901
LVASLGLSTSRPRVV

ZNF324

36

O75467
LSVRGTPSRALAERL

WWC2

386

Q6AWC2
ISSPAVERLISSLLR

ELAC2

616

Q9BQ52
LGARRLQESPSLSAL

SPEG

2156

Q15772
RESPLSLGLRLLSRS

SPEG

2341

Q15772
RSLEGSSDTALPLRR

PIK3R5

441

Q8WYR1
SSPLLLRRLSVEESG

SOWAHA

251

Q2M3V2
IDLSLPSLGLGRSRE

PLCH2

1156

O75038
ATPRTSLLRLTELES

SLC6A13

586

Q9NSD5
RGSVLASLSPLRKAS

FAM90A2P

176

Q658T7
LSRLSGVGLRLTTSL

CREBZF

281

Q9NS37
AERIPTLQTRGLSLS

TNNI1

46

P19237
ARLSRPDSGILASRI

POPDC2

326

Q9HBU9
LRDGGRLSATTVPLT

RFPL2

281

O75678
RALSLGTIPSLTRAD

TMEM201

451

Q5SNT2
GSGRLSTAITLLPLE

PHLDB1

46

Q86UU1
SAVLAARSARGLSLP

SLC66A3

26

Q8N755
ARSARGLSLPSLLLE

SLC66A3

31

Q8N755
TDARLRASTALLLPI

TOGARAM1

226

Q9Y4F4
LALRTRTAVTSLLSP

MRPL27

6

Q9P0M9
DLPLVIGSRSGLSSR

TXNIP

291

Q9H3M7
VSISSSPGLARKRSL

ZNF106

846

Q9H2Y7
LLSSLRPSLTGARRL

TERT

346

O14746
LDARGSNSLPLLRSV

TMEM33

131

P57088
LARASLALPTSSLSR

TRPV5

676

Q9NQA5
TLLSRTDLDPRVLSN

TNRC6B

606

Q9UPQ9
SSLSRLGSSRVLLLP

UBR5

286

O95071
LGSSRVLLLPLERDS

UBR5

291

O95071
PSLISIDLSSNRLSR

ELFN2

151

Q5R3F8
TVSLPELRSLLASGR

TSTD1

6

Q8NFU3
TLSRLSRTPIALATG

VAV3

111

Q9UKW4
LAESLPRRNSSLLSV

VPS13D

536

Q5THJ4
RGSVLASLSPLRKAS

FAM90A18

176

P0DV75
SRLDLTSNRLATLAP

LRFN4

196

Q6PJG9
ASERGVRLSLPRASS

PPP1R9B

86

Q96SB3